Polyhydroxylated fullerene nanoparticles attenuate brain infarction and oxidative stress in rat model of ischemic stroke by Rasouli Vani, Javad et al.
EXCLI Journal 2016;15:378-390 – ISSN 1611-2156 
Received: April 11, 2016, accepted: June 04, 2016, published: June 20, 2016 
 
 
378 
Original article: 
POLYHYDROXYLATED FULLERENE NANOPARTICLES  
ATTENUATE BRAIN INFARCTION AND OXIDATIVE STRESS  
IN RAT MODEL OF ISCHEMIC STROKE 
 
Javad Rasouli Vani1, Mohammad Taghi Mohammadi2*, Mahsa Sarami Foroshani1,  
Mahvash Jafari3 
 
1 Department of Nanotechnology, School of New Sciences and Technology, Islamic Azad 
University of Pharmaceutical Sciences Branch, Tehran, Iran 
2 Department of Physiology and Biophysics, School of Medicine, Baqiyatallah University of 
Medical Sciences, Tehran, Iran 
3 Department of Biochemistry, School of Medicine, Baqiyatallah University of Medical  
Sciences, Tehran, Iran 
 
* Corresponding author: Mohammad Taghi Mohammadi, PhD, Associated Professor of  
Physiology, Department of Physiology & Biophysics, School of Medicine, Baqiyatallah 
University of Medical Sciences, Tehran, Iran,  
Tel/Fax: +98 21 26127257, Mob: +98 9127713583,  
E-mail: Mohammadi.mohammadt@yahoo.com, Mohammadimohammadt@bmsu.ac.ir 
 
http://dx.doi.org/10.17179/excli2016-309 
 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 
(http://creativecommons.org/licenses/by/4.0/). 
 
 
 
ABSTRACT 
Oxidative stress is the common underlying mechanism of damage in ischemic stroke. Therefore, we aimed to 
evaluate the possible protective effects of polyhydroxylated fullerene derivatives on brain infarction and oxida-
tive/nitrosative stress in a rat model of ischemic stroke. The experiment was performed by four groups of rats 
(each;  n=12); Sham, Control ischemia, and ischemic treatment groups (Pretreatment and Posttreatment). Brain 
ischemia was induced by 90 min middle cerebral artery occlusion (MCAO) followed by 24 hours reperfusion. 
Rats received fullerene nanoparticles at dose of 1 mg/kg 30 min before MCAO and immediately after beginning 
of reperfusion. Infarct volume, contents of malondialdehyde (MDA), glutathione (GSH) and nitrate as well as 
superoxide dismutase (SOD) activity were assessed 24 hours after termination of MCAO. Brain infarct volume 
was 310 ± 21 mm3 in control group. Administration of fullerene nanoparticles before and after MCAO signifi-
cantly decreased the infarct volume by 53 % (145 ± 45 mm3) and 81 % (59 ± 13 mm3), respectively. Ischemia al-
so enhanced MDA and nitrate contents of ischemic hemispheres by 45 % and 25 % , respectively. Fullerene na-
noparticles considerably reduced the MDA and nitrate contents of ischemic hemispheres before MCAO by 58 % 
and 17 % , respectively, and after MCAO by 38 % and 21 % , respectively. Induction of MCAO significantly 
decreased GSH content (19 % ) and SOD activity (52 % ) of ischemic hemispheres, whereas fullerene nanoparti-
cles increased the GSH content and SOD activity of ischemic hemispheres by 19 % and 52 % before MCAO, re-
spectively, and 21 % and 55 % after MCAO, respectively. Our findings indicate that fullerene nanoparticles, as a 
potent scavenger of free radicals, protect the brain cells against ischemia/reperfusion injury and inhibit brain ox-
idative/nitrosative damage. 
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INTRODUCTION 
Oxidative stress is the common underly-
ing mechanism of damage in ischemic stroke 
(Niizuma et al., 2010; Chen et al., 2011; 
Rodrigo et al., 2013). It has been demon-
strated that free radicals lead to injuries in 
various cellular components including pro-
teins, lipids and DNA (Gilgun-Sherki et al., 
2002; Slemmer et al., 2008; Kleinschnitz et 
al., 2010). Previous findings have shown that 
about 2-5 % of the electron flow in isolated 
mitochondria from brain tissue generates re-
active oxygen species (ROS), (Bioveris and 
Chance, 1973). These continually generated 
ROS such as hydrogen peroxide (H2O2) and 
superoxide anion (O2-) are quenched by the 
brain antioxidant enzymes such as superox-
ide dismutase (SOD), glutathione peroxidase 
(GSHPx) and catalase (CAT), (Slemmer et 
al., 2008; Gill and Tuteja, 2010). On the oth-
er hand, these antioxidant enzymes are inac-
tivated when free radicals are overproduced 
by activation of pro-oxidant enzymes during 
brain ischemia (Kinouchi et al., 1991). Many 
pro-oxidant enzymes participate in free radi-
cals generation at ischemic brain such as 
xanthine oxidase (XO), nitric oxide synthase 
(NOS) and NADPH-oxidase (Chan, 2001; 
Miller et al., 2006; Ishizuka et al., 2008). 
Based on previous findings, upregulation of 
NADPH-oxidase is the main endogenous 
source of ROS during brain ischemia 
(Kehrer, 2000; Yoshioka et al., 2011). Nitric 
oxide (NO) is another poisonous free radical 
that is overproduced by different NOS 
isoforms during brain ischemia (Han et al., 
2006; Mohammadi et al., 2011; Mohammadi 
and Dehghani, 2015). Overproduction of NO 
in ischemic brain induces nitrosative damage 
(Parathath et al., 2006; Mohammadi et al., 
2012). Ultimately, combination of NO and 
ROS results in formation of very toxic com-
pound of peroxynitrite (ONOO-), which 
yields to the protein nitrotyrosination and 
cell death (Kehrer, 2000).  
Recently, fullerene (C60) nanoparticles, 
which are the third allotrope of carbon atoms 
in spherical structure, have been presented as 
the powerful antioxidants in biological sys-
tems (Lens et al., 2008; Markovic and 
Trajkovic, 2008; Liao et al., 2010). They can 
easily react with electrons and abolish differ-
ent free radicals (Chistyakov et al., 2013). 
Based on recent findings, these nanoparticles 
are able to scavenge various free radicals 
more efficiently than cellular antioxidants 
(Cai et al., 2008; Chistyakov et al., 2013). 
Since fullerene nanoparticles are not soluble 
in biological environments, they must be wa-
ter-soluble by adding the functional groups 
such as carboxyl (COOH) or hydroxyl (OH) 
(Injac et al., 2013). Fullerene hydroxylation, 
which widely used as a scavenger in plenti-
ful research, is suitable for this purpose (Kim 
et al., 2008; Chistyakov et al., 2013). Degu-
chi et al.  (2006) showed the antioxidant ac-
tivities of hydroxyl fullerenes in aqueous en-
vironments. Kim et al. (2008) demonstrated 
that hydroxyl fullerenes are able to protect 
neurons against transient global cerebral in-
jury in rat hippocampus. Zha et al. (2012) 
reported that fullerenol in cultured hippo-
campal neurons protects against cell damage 
and promotes cell viability mainly due to its 
influence on reduction-oxidation pathways. 
Additionally, intracerebroventricular admin-
istration of fullerene (0.3 mg/kg) had a pro-
tective effect against ischemia/reperfusion 
injury (Lin et al., 2002). Finally, Ye et al. 
(2014) reported that polyhydroxylated fuller-
ene attenuates oxidative stress-induced apop-
tosis via a fortifying Nrf2-regulated cellular 
antioxidant system. 
According to previous findings that wa-
ter-soluble fullerene derivatives have free 
radical scavenging properties, we aimed to 
examine the possible protective effects of 
polyhydroxylated fullerene derivatives 
(C60(OH)18-22) against ischemia/reperfusion-
induced brain damage in rat model of is-
chemic stroke. Additionally, we analyzed the 
possible protective role of this compound 
against oxidative or nitrosative damage, 
which induced by brain ischemia. 
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MATERIALS AND METHODS 
Animals 
Male Wistar rats, 10-12 weeks old (280-
320 g), were purchased from the animal 
house facility of Baqiyatallah University of 
Medical Sciences. The protocols of present 
study, which followed the NIH Guidelines 
for animals use and care, were approved by 
the institutional animal ethics committee of 
Baqiyatallah University of Medical Sciences. 
Rats were kept in the separate cages in a 
room with controlled temperature (22-
24° C), light period (07.00-19.00), and hu-
midity (40-60 % ). All animals access to rat 
chow and water ad libitum. 
 
Middle cerebral artery (MCA) occlusion  
Animals had been fasted overnight prior 
to use without deprivation of water. The rats 
were anesthetized with 2.5 % isoflorane (Fo-
rane, UK) and placed in dorsal recumbent 
position. Core temperature was maintained at 
37 ± 1° C during the experiment using with a 
heating pad and continuous recording by a 
rectal probe connected to a thermistor.  
Intraluminal filament method was used 
for middle cerebral artery occlusion 
(MCAO) of the right brain hemisphere to 
achieve brain ischemia (Longa et al., 1989). 
“In brief, the right common carotid artery 
was exposed through a midline neck inci-
sion, and then, via external carotid artery, a 
4-cm Poly-L-Lysine-coated nylon thread (3-
0) was inserted into the internal carotid ar-
tery and gently advanced up until feeling a 
resistance and seeing a sharp decline in the 
blood flow trace. MCAO was maintained for 
90 min, and then the thread was gently taken 
out to reestablish blood flow to the ischemic 
region. Finally, all the incisions were su-
tured, the animals were allowed to recover 
from anesthesia, and returned to a warm cage 
for recuperation during reperfusion period. 
Regional cerebral blood flow (rCBF) for the 
area of the right hemisphere that was nour-
ished by the right middle cerebral artery 
(MCA) was recorded using a laser Doppler 
flowmeter (AD Instrument, Model: ML191, 
Australia). There was a 75-85 % reduction in 
rCBF of ischemic groups during MCA oc-
clusion (Figure 1). This reduction returned 
swiftly back to its pre-occluded level during 
the first 15 min of reperfusion period” 
(Mohammadi and Dehghani, 2015). 
 
Experimental protocols and groups 
In Sham rats (n=12), the animals under-
went the surgery at the neck area and re-
ceived a single intraperitoneal injection of 
the 1 mL/kg normal saline, as vehicle, with-
out being exposed to MCA occlusion. Sur-
gery was performed at the neck region of 
control ischemic rats (Control, n=12) same 
as sham group. These animals received a 
single intraperitoneal injection of the 
1 mL/kg normal saline, as vehicle, 30 min 
before MCA occlusion. After a 15 min rest, 
brain ischemia was performed by 90 min 
MCAO followed by 24 hours reperfusion. 
The rats of the ischemic pretreatment group 
(Pretreatment, n=12) received a single i.p. 
injection of 1 mg/kg polyhydroxylated full-
erenes (Sigma, Germany) in 1 mL normal sa-
line 30 min before induction of MCAO and 
other procedures were followed same as con-
trol group. The ischemic posttreatment group 
(Posttreatment, n=12) received a single i.p. 
injection of 1 mg/kg polyhydroxylated full-
erenes in 1 mL normal saline immediately 
after termination of MCAO and beginning of 
reperfusion. Other protocols were followed 
the same as control group. 
The number of rats presented for each 
group is the number of animals that survived 
during twenty four hours reperfusion period. 
The collected data of the rats that died in 
twenty four hours reperfusion period were 
excluded. The percent of mortality in control 
ischemia, pretreatment and posttreatment 
groups was 38 %, 13 % and 9 %, respective-
ly.  
 
Neurological assessment 
Neurological functions were assessed at 
the beginning and twenty four hours of 
reperfusion in animals that survived the is-
chemic trauma and at same time periods in 
the sham rats. “A five-point grading scale of 
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Figure 1: Regional cerebral blood flow (rCBF; % from baseline) before and during MCAO, and in the 
early reperfusion period in Sham, Control, Pretreatment and Posttreatment groups. All values are 
mean ± SEM. * as significant difference compared with Sham (P < 0.05) 
 
 
neurological deficit scores (NDS) was used, 
in which rats with normal motor function or 
no observable neurological deficits were as-
signed as grade 1. Grade 2 was given to rats 
that showed flexion of contralateral torso or 
forelimb upon lifting by their tail, or failure 
to extend their forepaw when suspended ver-
tically, forelimb flexion and shoulder adduc-
tion. Grade 3 was for rats circling to the con-
tralateral side of the MCA occluded hemi-
sphere when the animal is held by the tail on 
a flat surface, but with normal posture at rest. 
Grade 4 was assigned to the loss of righting 
reflex and decreased resistance to lateral 
push, and finally, grade 5 was for no sponta-
neous motor activity” (Mohammadi et al., 
2012). 
 
Evaluation of brain infarction 
Brain infarction was assessed according 
to the 2, 3, 5-triphenyltetrazolium chloride 
(TTC, Sigma) staining method. “In brief, af-
ter induction of deep anesthesia with sodium 
thiopental, the animals were slaughtered. 
Then, their brains were removed, cleaned, 
and solidified by immersing in pre-cooled 
normal saline (4° C) and keeping in the re-
frigerator for 5 min. The prepared slices 
were stained with 2 % TTC and fixed in 
10 % buffered formalin solution. After stain-
ing, the color of the ischemic areas was 
white and of non-ischemic areas was red. 
The slice images were digitized by using a 
Cannon camera. Images of the stained sec-
tions were taken. Grossly visible infarction 
zones were quantified using image analysis 
software (NIH Image Analyzer) and finally 
cerebral infarct volume was calculated as de-
scribed previously” (Sarshoori et al., 2014). 
 
Tissue swelling 
Twenty four hours after reperfusion the 
rats were killed and the brains were re-
moved. The brain divided into two hemi-
spheres. Olfactory bulb and brain stem were 
removed and determined their total volume 
of hemispheres based on infarct volume 
method (Swanson et al., 1990). Tissue swell-
ing percentage was calculated using the fol-
lowing formula: 
 
100x  ]
phereLeft Hemis
V/
  phere)Left Hemis
V- 
sphereRight Hemi
[(V  swelling Tissue % 
 
Tissue preparation 
After deep anesthesia, brains were quick-
ly removed, washed in an ice-cold phosphate 
buffer saline (PBS) for assessment of 
malondialdehyde (MDA), glutathione (GSH) 
and nitrate contents as well as superoxide 
dismutase (SOD) activity. Tissues were im-
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mediately immersed in liquid nitrogen and 
kept on -80° C until biochemical analysis. 
On the day of use, the frozen samples were 
weighed and homogenized 1:10 in ice-cold 
PBS. The homogenates were then centri-
fuged at 14000×g for 15 min at 4° C. The 
supernatants were separated and used for 
measurement of GSH, MDA, nitrate and pro-
tein concentrations as well as SOD activity. 
 
Determination of glutathione (GSH)  
content  
The content of glutathione (GSH) was 
measured using the Tietz method (Tietz, 
1969). Cellular protein was precipitated by 
addition of 5 % sulfosalicylic acid and re-
moved by centrifugation at 2000 g for 10 
min. GSH in the supernatant was assayed as 
follows: 100 µL of the protein-free superna-
tant of the cell lysate, 800 µL of 0.3 mM 
Na2HPO4 and 100 µL of 0.04 % 5,5′-
dithiobis-(2-nitrobenzoic acid) (DTNB) in 
0.1 % sodium citrate. The absorbance of 
DTNB was monitored at 412 nm for 5 
minutes. A standard curve of GSH was per-
formed and sensitivity of measurement was 
determined to be between 1 and 100 µM. 
The level of GSH was expressed as µg/mg 
protein” (Mohammadi et al., 2013). 
 
Assessment of SOD activity 
The SOD activity was determined using 
the method described by Winterbourn et al. 
(1975) based on the ability of SOD to inhibit 
the reduction of nitroblue tetrazolium (NBT) 
by superoxide. “For assay, 0.067 M potassi-
um phosphate buffer, pH 7.8 was added to 
0.1 M EDTA containing 0.3 mM sodium cy-
anide, 1.5 mM NBT and 0.1 mL of sample. 
Then, 0.12 mM riboflavin was added to each 
sample to initiate the reaction and was incu-
bated for 12 min. The absorbance of samples 
was read on a Genesys 10 UV spectropho-
tometer at 560 nm for 5 minutes. The 
amount of enzyme required to produce 50 % 
inhibition was taken as 1 U and results were 
expressed as U/mg protein” (Mohammadi et 
al., 2013). 
 
Determination of MDA as an index of lipid 
peroxidation 
The end product of lipid peroxidation 
was estimated by measuring the level of 
MDA according to the Satoh method (Satoh, 
1978). “0.5 mL of tissue homogenate was 
added to 1.5 mL of 10 % trichloroacetic acid 
(TCA), vortexed and incubated for 10 min at 
room temperature. 1.5 mL of supernatant and 
2 mL of thiobarbituric acid (0.67 % ) were 
added and placed in a boiling water bath in 
sealed tubes for 30 min. The samples were 
allowed to cool at room temperature. 1.25 
mL of n-butanol was added, vortexed and 
centrifuged at 2000 g for 5 min. The result-
ing supernatant was removed and measured 
at 532 nm on a spectrophotometer. MDA 
concentrations were determined by using 
1,1,3,3-tetraethoxypropane as standard. Fi-
nally, the MDA concentration was expressed 
as µg/mg protein” (Mohammadi et al., 
2013). 
 
Nitrate assay 
The nitrate content of the brain was 
measured by the colorimetric reaction of the 
Griess reagent (Riahi et al., 2016). 0.1 mL of 
homogenate solution was deproteinized by 
adding 0.2 mL of zinc sulfate solution and 
then centrifuged for 20 min at 4000 g and 
4° C to separate supernatant for nitrate assay. 
0.1 mL of supernatant (as sample) or pure 
water (as blank) or sodium nitrite (as stand-
ard) was mixed with 0.1 mL vanadium III 
chloride to reduce nitrite to nitrate. 0.05 mL 
sulfanilamide (0.01 % ) and 0.05 mL N-[1-
naphthyl] ethylenediamindihydrochloride 
(NED, 0.01 % ) were incubated for 30 min in 
dark place at 37° C. Thereafter, the absorb-
ance of solution was determined at wave 
length of 540 nm. Nitrate concentration was 
estimated from a standard curve generated 
from absorbance of each sodium nitrate solu-
tion. Finally, the nitrate level was expressed 
as µg/mg protein. 
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Assessment of protein concentration 
The concentration of protein was as-
sessed according to the Bradford method us-
ing bovine serum albumin (BSA) as a stand-
ard (Bradford, 1976). 
 
Statistical analysis 
All values are presented as mean ± SEM. 
The comparison of data between groups 
were done by analysis of variance (ANOVA) 
followed by Tukey post-hoc test. The Mann-
Whitney U test was used to analyze the 
NDS. For all states, P < 0.05 was considered 
as a significant difference. 
 
RESULTS 
Regional cerebral blood flow (rCBF) 
Representative changes of rCBF (% from 
baseline) with time are shown in Figure 1. 
There was no significant difference in the 
rCBF of sham rats with time. Whereas, 
MCAO drastically reduced rCBF to about 
15-25 % of their own baselines in ischemic 
groups (control, pretreatment and posttreat-
ment). Results of rCBF for the ischemic rats 
indicated that treatments of ischemic animals 
with polyhydroxylated fullerenes did not sta-
tistically change the blood flow of the is-
chemic areas during ischemia or in the early 
reperfusion period. 
 
Neurological deficit score (NDS) 
Figure 2 represents the neurological dis-
abilities (NDS) of ischemic groups at the be-
ginning (A) and 24 hours (B) of reperfusion. 
The graph A is indicating that there were se-
vere motor disabilities in ischemic groups 
(control, pretreatment and posttreatment) af-
ter occlusion of MCA. There was no signifi-
cant difference in the values of NDS between 
ischemic groups following one hour reperfu-
sion. Pretreatment and posttreatment with 
polyhydroxylated fullerenes showed a signif-
icant improvement of neurological disabili-
ties following 24 hours reperfusion (graph 
B).  
 
Brain infarction  
Qualitative evaluation of brain infarction 
is performed by the preparation of coronal 
sections stained with TTC (Figure 3, left 
hand). The uniform red color of the sections 
of right and left hemispheres in sham rats in-
dicated that the surgery did not induce in-
farction. The presence of white color areas 
intermingled with red color regions in the 
right hemispheres of ischemic rats (control, 
 
  
Figure 2: Neurological deficit score (NDS). (A): one hour after neck surgery in Sham or after 90 min 
MCAO in ischemic groups (Control, Pretreatment and Posttreatment), (B): 24 hours after neck surgery 
in Sham or after 90 min MCAO and 24 hours reperfusion in ischemic groups. All values are as 
Mean ± SEM. * as significant difference compared with Control (P < 0.05); ** as significant difference 
compared with Control (P < 0.01) 
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Figure 3: Photograph (left hand) is showing the coronal sections of rat’s brain stained with triphenyl-
tetrazolium chloride (TTC) 24 hours after neck surgery in Sham or after 90 min MCAO and 24 hours 
reperfusion in Control, Pretreatment and Posttreatment groups. Non-ischemic areas are colored deep 
red, whereas ischemic areas are white (Scale bar; 1 cm). The graph (right hand) is showing the in-
farct volume (mm3) for mentioned groups at the same time. All values are as Mean ± SEM. * as signif-
icant difference compared with Control (P < 0.01); ** as significant difference compared with Control 
(P < 0.001) 
 
 
pretreatment and posttreatment) indicated 
that 90 min right MCAO provoked different 
magnitudes of brain infarctions without af-
fecting the left hemispheres. The compari-
sons of the white color areas of the lesioned 
hemispheres of ischemic rats indicated that 
polyhydroxylated fullerenes attenuated the 
infarct size in both treated groups. Quantifi-
cation of the ischemic areas of lesioned hem-
ispheres indicated that MCA occlusion con-
siderably induced brain infarction (310 ± 21 
mm3). Pretreatment and posttreatment with 
polyhydroxylated fullerenes significantly at-
tenuated the brain infarction in both treated 
groups (145 ± 45 mm3 and 59 ± 13 mm3, re-
spectively), (Figure 3, right hand). 
 
Tissue swelling of the ischemic  
hemispheres  
The calculated percentage of tissue 
swelling (brain swelling) of MCA occluded 
hemispheres (right hemisphere) are present-
ed in Figure 4. The value of brain swelling in 
sham group was zero. Occlusion of MCA in-
duced tissue swelling (12.08 ± 0.08 % ) fol-
lowing 24 hours reperfusion in control is-
chemic rats, whereas there was an 84 % and 
61 % reduction in brain swelling in pre-
treatment (1.84 ± 0.69 % ) and posttreatment 
(4.63 ± 2.52 % ) groups, respectively.  
 
 
Figure 4: Tissue swelling (%) of right hemi-
spheres 24 hours after neck surgery in Sham or 
after 90 min MCAO followed by 24 hours reper-
fusion in ischemic groups (Control, Pretreatment 
and Posttreatment). All values are as 
Mean ± SEM. * as significant difference com-
pared with Control (P < 0.05); ** as significant 
difference compared with Control (P < 0.01) 
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SOD activity and GSH content of ischemic 
hemispheres  
Figure 5 denotes the relative SOD activi-
ty (A) and GSH content (B) of ischemic 
hemispheres (right hemispheres) after 
90 min MCA occlusion followed by 
24 hours reperfusion. The results of ischemic 
brain are indicating that occlusion of MCA 
decreased the SOD activity of control is-
chemic group (2.52 ± 0.75 U/mg protein) 
compared to sham (5.30 ± 0.76 U/mg pro-
tein). Ischemia also decreased the GSH con-
tent of ischemic group (434 ± 47 µg/mg pro-
tein) compared with sham (610 ± 54 µg/mg 
protein). Treated rats with polyhydroxylated 
fullerenes showed a significant increment of 
SOD activity in both pretreatment 
(5.35 ± 0.57 U/mg protein) and posttreat-
ment (5.59 ± 0.96 U/mg protein) groups. 
Furthermore, the total GSH content of is-
chemic hemispheres increased in both pre-
treatment (536 ± 39 µg/mg protein) and post-
treatment (553 ± 41 µg/mg protein) groups 
but these changes did not statistically differ 
compared to control group.  
MDA and nitrite contents of ischemic  
hemispheres 
Figure 6 shows the MDA (A) and nitrate 
(B) contents of ischemic hemispheres (right 
hemispheres) after 90 min MCA occlusion 
followed by 24 hours reperfusion. The re-
sults of ischemic brains indicate that occlu-
sion of MCA increased the MDA content of 
control group (2.74 ± 0.37 µg/mg protein) 
compared to sham (1.49 ± 0.22 µg/mg pro-
tein). Ischemia also enhanced the nitrate con-
tent of control group (19.41 ± 02.20 µg/mg 
protein) compared to the sham (14.50 ± 
0.25 µg/mg protein). Treated rats with poly-
hydroxylated fullerenes showed a significant 
reduction of MDA in both treated groups fol-
lowing 24 hours reperfusion (pretreatment; 
1.14 ± 0.48 µg/mg protein, posttreatment; 
1.71 ± 0.43 µg/mg protein). Furthermore, the 
nitrate content of ischemic hemispheres de-
creased in both pretreatment (16.18 ± 
0.65 µg/mg protein) and posttreatment 
(15.32 ± 1.02 µg/mg protein) groups com-
pared to control.  
 
 
 
   
Figure 5: A; The activity of superoxide dismutase (SOD, U/mg protein), and B; Glutathione (GSH) 
content (µg/mg protein), of right hemispheres in Sham group 24 hours after neck surgery or after 90 
min MCAO and 24 hours reperfusion in Control, Pretreatment and Posttreatment groups. All values 
are as Mean ± SEM. * as significant difference compared with Sham (P < 0.05); $ as significant differ-
ence compared with Control (P < 0.05) 
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Figure 6: A; Representative changes of malondialdehyde (MDA) content (µg/mg protein), and B; ni-
trate content (µg/mg protein), of right hemispheres in Sham group 24 hours after neck surgery or after 
90 min MCAO and 24 hours reperfusion in Control, Pretreatment and Posttreatment groups. All values 
are as Mean ± SEM. * as significant difference compared with Sham (P < 0.05); $ as significant differ-
ence compared with Control (P < 0.05) 
 
 
DISCUSSION 
Recently, several nanoparticles have 
been introduced for a wide variety of biolog-
ical applications (Cai et al., 2008; 
Chistyakov et al., 2013). Previous studies 
have shown that water-soluble fullerene de-
rivatives are able to quench all of the major 
physiologically relevant ROS like superox-
ide anion and protect the cells against oxida-
tive damages (Lens et al., 2008; Markovic 
and Trajkovic, 2008; Liao et al., 2010). In 
the present study, we indicated the protective 
effects of polyhydroxylated fullerene nano-
particles (C60(OH)18-22) against brain ische-
mia/reperfusion injury in rat. Using a rat 
model of transient MCA occlusion, we 
showed the protective effects of these nano-
particles on brain infarction. Our findings 
revealed a decrease in oxidative/nitrosative 
damage of ischemic brain by fullerene nano-
particles. Also, these nanoparticles potentiat-
ed the brain antioxidant system of ischemic 
treated rats compared to ischemic untreated 
animals. It is suggested that fullerene nano-
particles, as a powerful scavenger of free 
radicals, protect the brain cells against is-
chemia/reperfusion-induced brain damage. 
In the present study, intraperitoneal ad-
ministration of polyhydroxylated fullerenes 
(1 mg/kg) significantly decreased the neuro-
logical score (NDS), infarct volume and tis-
sue swelling of ischemic hemispheres in both 
treated groups (pretreatment and posttreat-
ment). Our findings indicate that polyhy-
droxylated fullerenes during ischemia or 
reperfusion phase are able to improve the in-
juries of ischemic stroke. Based on previous 
studies, functionalized fullerenes interfere in 
processes of the ischemic cascades such as 
inflammation, oxidative stress, apoptotic 
cascades and other neurotoxic pathways, 
which play critical roles in pathophysiology 
of ischemic stroke (Markovic and Trajkovic, 
2008; Zha et al., 2012; Fluri et al., 2015). 
Fluri et al. (2015) demonstrated the anti-
inflammatory properties of functionalized 
fullerenes following brain ischemia. In other 
studies, Yin et al. (2009) and Markovic and 
Trajkovic (2008) reported the ability of full-
erene derivatives to quench various free rad-
icals and behave as a free radical sponge. Al-
so, the study of Hu et al. (2010) indicated 
that water-soluble fullerene derivatives have 
the potential to prevent NO-mediated cell 
death without evident toxicity. All of the 
previous reports confirm that water-soluble 
fullerenes have a great ability to protect the 
different cells against apoptosis, particularly 
neurons. Furthermore, the protective effects 
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of water-soluble fullerene derivatives against 
ischemia/reperfusion injuries have been re-
ported in other tissues such as intestine and 
in other in vitro organ perfusate (Chueh et 
al., 1999; Bisaglia et al., 2000). These obser-
vations indicate the potential therapeutic 
properties of the functionalized fullerene de-
rivatives to prevent the injuries of ischemic 
stroke. 
The findings of present study indicated 
that brain contents of MDA (an index of oxi-
dative damage) and nitrate (an index of ni-
trosative damage) considerably enhanced af-
ter induction of brain ischemia/reperfusion. 
A large number of in vitro and in vivo stud-
ies suggest that ROS and nitrogen reactive 
species (RNS) are involved in pathophysiol-
ogy of brain ischemia/reperfusion injuries 
(Niizuma et al., 2010; Chen et al., 2011; 
Rodrigo et al., 2013). These free radicals in-
teract with various biomolecules of cells re-
sulting in lipid peroxidation, DNA damage, 
protein modification and alterations in en-
zymatic activities, ultimately leading to 
apoptotic or necrotic cell death (Gilgun-
Sherki et al., 2002; Slemmer et al., 2008; 
Kleinschnitz et al., 2010). Our results indi-
cated that using polyhydroxylated fullerenes 
before or after MCA occlusion greatly de-
creased the contents of brain MDA and ni-
trate. It is well known that water-soluble 
fullerene derivatives possess a great capacity 
for scavenging ROS and RNS (Markovic and 
Trajkovic, 2008; Hu et al., 2010). Yin et al. 
(2009) reported the scavenging of ROS and 
the potential for cell protection by function-
alized fullerene materials. Markovic and 
Trajkovic (2008) demonstrated that fullerene 
nanoparticles have a potential ability to 
quench ROS, behaving as a ‘‘free radical 
sponge’’. Likewise, it has been demonstrated 
that polyhydroxylated fullerene (C60(OH)24) 
was able to quench NO and block its biolog-
ical activity in vivo (Hu et al., 2010). Ac-
cording to the study of Misirkic et al. (2009) 
fullerene nanoparticles might be candidate 
for preventing NO-mediated cell injury in in-
flammatory or autoimmune disorders. Final-
ly, the capability of polyhydroxylated fuller-
ene derivatives acting as ROS or RNS scav-
enger has been shown to be involved in inhi-
bition of apoptosis in different types of cells 
both in vitro and in vivo (Bisaglia et al., 
2000; Hu et al., 2010). 
Our results indicate that the activity of 
SOD and total GSH content of brain have 
decreased in ischemic hemispheres. SOD is 
an important antioxidant enzyme of brain 
that quenches the superoxide anion in mito-
chondrial matrix (Rowley and Patel, 2013). 
Based on previous findings, a decrease in the 
SOD level during brain ischemia promotes 
the neural death and brain damages 
(Slemmer et al., 2008). Likewise, GSH is an 
intracellular element of brain cells that plays 
a crucial role in cellular protection against 
oxidant damage during brain ischemia (Song 
et al., 2015). A decrease in cellular GSH 
content following brain ischemia induces the 
release of cytochrome c, which initiates the 
apoptotic signaling cascades (Schafer and 
Buettner, 2001). In the present study, using 
polyhydroxylated fullerenes in ischemic rats 
increased the activity of SOD and total GSH 
content of ischemic brain. It is suggested that 
increased the SOD activity and total GSH 
content of brain in ischemic treated rats by 
polyhydroxylated fullerenes correlates with 
reduction of oxidative damage and brain in-
farction. Song et al. (2015) reported that 
GSH might improve the pathogenesis of is-
chemic stroke by attenuating brain infarction 
and cell death. In addition, it is reported that 
the increment of SOD activity during brain 
ischemia ameliorates oxidative damage and 
improve ischemia/reperfusion-induced brain 
damages (Li et al., 2015). However, other 
studies need to elucidate the direct effects of 
polyhydroxylated fullerenes on the activities 
of brain antioxidant enzymes and brain GSH 
in ischemic stroke. 
In conclusion, the findings of present 
study indicate that polyhydroxylated fuller-
ene nanoparticles (C60(OH)18-22) are able to 
improve the brain ischemia/reperfusion-
induced neuronal death and brain damages. 
Based on our findings, polyhydroxylated 
fullerenes inhibit the oxidative and nitrosa-
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tive damages of the ischemic brain that may 
be related to improving the brain antioxidant 
system.  
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